Anyway some are suggesting a zero dividend is a possibility, I would like to believe that because guidence looks like it's reaching the levels we saw in 2013 ( https://markets.theaustralian.com.au/shares/RFG/retail-food-group-limited) when dividends were at 10c / half .. I'd be happy to see it go to that ?!
Except that you can't just look at one element of the company's financials in isolation; you need to view it the context of the overall financial position of the company:
In 2013 RGF's Net Debt was $92m; today it is $240m.
So, same level of earnings, but indebtedness 2.6 times higher now.
Put another way, RFG's earnings were supporting debt levels less than 3 times higher; today RFG's net borrowings are 7.5 times higher than the company's earnings.
Big difference in circumstances.
I'd say that if the board declared a dividend now, it would be acting in a fiscally irresponsible manner. If I was a shareholder in this company, I'd be thinking that the repair of the balance sheet was a priority.
- Forums
- ASX - By Stock
- RFG
- Ann: Guidance Update for 1H18
Ann: Guidance Update for 1H18, page-111
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RFG (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.5¢ |
Change
0.004(5.63%) |
Mkt cap ! $186.9M |
Open | High | Low | Value | Volume |
6.8¢ | 7.6¢ | 6.8¢ | $647.9K | 8.894M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 309945 | 7.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.5¢ | 116290 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 309945 | 0.074 |
1 | 27233 | 0.073 |
2 | 147000 | 0.072 |
1 | 50000 | 0.071 |
3 | 1050000 | 0.070 |
Price($) | Vol. | No. |
---|---|---|
0.075 | 116290 | 1 |
0.076 | 245385 | 3 |
0.077 | 324761 | 10 |
0.078 | 313076 | 4 |
0.079 | 1007765 | 7 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
RFG (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online